PFIZER REPORTS THIRD-QUARTER 2018 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Pfizer (PFE) PT Raised to $42 at Credit Suisse
October 31, 2018 8:56 AM EDTCredit Suisse analyst Vamil Divan raised the price target on Pfizer (NYSE: PFE) to $42.00 (from $40.00) while maintaining a Neutral rating.
... MorePfizer (PFE) Tops Q3 EPS by 3c
October 30, 2018 6:47 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $0.78, $0.03 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.53 billion.
GUIDANCE:
Pfizer sees FY2018 EPS of $2.98-$3.02, versus the consensus of $2.99.Now... More